Beijing Aosaikang Pharmaceutical: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Beijing Aosaikang Pharmaceutical Co., Ltd.
Beijing Aosaikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Beijing Aosaikang Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for injectable isaconazole sulfate
Beijing Aosaikang Pharmaceutical: Verification Report on the 2023 Operating Income Deduction Status Table
Beijing Aosaikang Pharmaceutical: 2024 First Quarter Report
Beijing Aosaikang Pharmaceutical: Internal Control Audit Report
Beijing Aosaikang Pharmaceutical: External guarantee management system (2024)
Beijing Aosaikang Pharmaceutical: Investor Relations Management System (2024)
Beijing Aosaikang Pharmaceutical: Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accountants in the 2023 annual review
Beijing Aosaikang Pharmaceutical: Insider Information Insider Registration Management System (2024)
Beijing Aosaikang Pharmaceutical: Information Disclosure Management System (2024)
Beijing Aosaikang Pharmaceutical: Announcement of Board Resolutions
Beijing Aosaikang Pharmaceutical: 2023 Annual Financial Report
Beijing Aosaikang Pharmaceutical: 2023 Independent Director Debriefing Report (Liu Jianwen)
Beijing Aosaikang Pharmaceutical: Internal reporting system for important information (2024)
Beijing Aosaikang Pharmaceutical: Board Audit Committee Annual Report Work Procedure (2024)
Beijing Aosaikang Pharmaceutical: Independent Director Work System (2024)
Beijing Aosaikang Pharmaceutical: Evaluation report on the performance of accounting firms in 2023
Beijing Aosaikang Pharmaceutical: Independent Director's Annual Debriefing Report
Beijing Aosaikang Pharmaceutical: Board Remuneration and Assessment Committee Rules of Procedure (2024)
No Data